当前位置:首页 - 行情中心 - 科源制药(301281) - 财务分析 - 现金流量表

科源制药

(301281)

  

流通市值:31.70亿  总市值:48.38亿
流通股本:7095.20万   总股本:1.08亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金73,885,748.85299,180,405.94202,183,174.02142,475,971.31
  收到的税费返还-502,727.86566,215.25566,215.25
  收到其他与经营活动有关的现金44,649,924.8239,899,125.3516,120,255.68,842,411.23
  经营活动现金流入小计118,535,673.67339,582,259.15218,869,644.87151,884,597.79
  购买商品、接受劳务支付的现金31,978,248.4496,777,908.1648,600,286.1333,748,514.34
  支付给职工以及为职工支付的现金26,878,547.69109,436,259.1183,313,526.1359,518,351.92
  支付的各项税费3,476,826.5914,707,958.814,860,780.2211,657,301.62
  支付其他与经营活动有关的现金25,080,071.7975,191,055.3944,855,131.0621,390,650.4
  经营活动现金流出小计87,413,694.51296,113,181.46191,629,723.54126,314,818.28
  经营活动产生的现金流量净额31,121,979.1643,469,077.6927,239,921.3325,569,779.51
二、投资活动产生的现金流量:
  收回投资收到的现金-596,708,619.72490,040,412.48443,020,967.55
  取得投资收益收到的现金1,200,183.934,617,837.072,012,729.81,872,579.95
  处置固定资产、无形资产和其他长期资产收回的现金净额-500,578.99198,96815,318
  收到的其他与投资活动有关的现金7,100,000-21,085,848.52-
  投资活动现金流入小计8,300,183.93601,827,035.78513,337,958.8444,908,865.5
  购建固定资产、无形资产和其他长期资产支付的现金27,630,358.68137,050,696.11108,642,394.9290,982,620.56
  投资支付的现金9,000,000343,322,620.87534,330,041.67292,262,295.25
  支付其他与投资活动有关的现金-38,011.25--
  投资活动现金流出小计36,630,358.68480,411,328.23642,972,436.59383,244,915.81
  投资活动产生的现金流量净额-28,330,174.75121,415,707.55-129,634,477.7961,663,949.69
三、筹资活动产生的现金流量:
  取得借款收到的现金44,398,432.4570,161,627.8955,395,301.3853,617,376.08
  筹资活动现金流入小计44,398,432.4570,161,627.8955,395,301.3853,617,376.08
  偿还债务支付的现金40,0003,558,384.983,478,384.983,478,384.98
  分配股利、利润或偿付利息支付的现金1,158,514.6224,820,297.3823,948,271.3721,664,494.54
  筹资活动现金流出小计1,198,514.6228,378,682.3627,426,656.3525,142,879.52
  筹资活动产生的现金流量净额43,199,917.8341,782,945.5327,968,645.0328,474,496.56
四、汇率变动对现金及现金等价物的影响-204,929.59453,917.96488,714.31513,591.9
五、现金及现金等价物净增加额45,786,792.65207,121,648.73-73,937,197.12116,221,817.66
  加:期初现金及现金等价物余额298,891,416.9491,769,768.2191,769,768.2191,769,768.21
  期末现金及现金等价物余额344,678,209.59298,891,416.9417,832,571.09207,991,585.87
补充资料:
  净利润-16,376,551.12-42,641,961.6
  资产减值准备-19,476,562.68-1,351,026.66
  固定资产和投资性房地产折旧-45,382,820.03-22,409,934.29
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-45,382,820.03-22,409,934.29
  无形资产摊销-6,588,819.94-3,125,198.95
  长期待摊费用摊销-303,526.17-146,029.14
  处置固定资产、无形资产和其他长期资产的损失--303,640.29--
  固定资产报废损失-565,413.44-38,829.6
  公允价值变动损失----50,958.9
  财务费用--437,347.32--497,021.26
  投资损失--5,925,403.13--69,714.93
  递延所得税--687,897.25--1,541,444.62
  其中:递延所得税资产减少--1,204,353.49--245,182.58
    递延所得税负债增加-516,456.24--1,296,262.04
  存货的减少--34,262,804.34--18,602,539.91
  经营性应收项目的减少--31,870,729.66--14,143,846.76
  经营性应付项目的增加-28,263,206.3--9,237,674.35
  现金的期末余额-298,891,416.94-207,991,585.87
  减:现金的期初余额-91,769,768.21-91,769,768.21
  现金及现金等价物的净增加额-207,121,648.73-116,221,817.66
公告日期2026-04-242026-04-162025-10-242025-08-16
审计意见(境内)标准无保留意见
TOP↑